Total planned funding: $280,757,923
Clear active filters
John Snow, Inc
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Zambia | $90,594,991 |
Uganda | $41,795,642 |
Tanzania | $35,494,237 |
Eswatini | $17,263,021 |
Mozambique | $16,230,753 |
South Africa | $11,591,442 |
Ethiopia | $11,152,213 |
Nigeria | $10,600,000 |
Ghana | $8,224,934 |
Botswana | $6,832,606 |
Dominican Republic | $5,918,127 |
Malawi | $5,566,156 |
Rwanda | $3,120,152 |
Caribbean Region | $3,115,000 |
Kenya | $2,642,610 |
Haiti | $2,621,170 |
Côte d'Ivoire | $2,412,646 |
Guyana | $1,736,289 |
Zimbabwe | $1,668,734 |
Lesotho | $800,000 |
Indonesia | $700,000 |
Namibia | $527,200 |
Central America Region | $150,000 |
South Sudan | $0 |
India | $0 |
Ukraine | $0 |
Organizational Types
Implementing Agency | $144,822,465 |
Private Contractor | $129,590,947 |
NGO | $6,344,511 |
Program Areas
Prevention | $108,477,868 |
Treatment | $66,916,407 |
Care | $44,585,511 |
Governance and Systems | $42,036,019 |
Testing | $17,244,120 |
Budget Codes
HTXS: Treatment: Adult Treatment | $55,026,045 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $47,352,811 |
HMIN: Biomedical Prevention: Injection Safety | $30,986,108 |
OHSS: Health Systems Strengthening | $24,150,953 |
HBHC: Care: Adult Care and Support | $20,505,143 |
HVCT: Testing: HIV Testing and Counseling | $17,244,120 |
HVOP: Sexual Prevention: Other Sexual Prevention | $14,453,707 |
HKID: Care: Orphans and Vulnerable Children | $13,937,851 |
HVSI: Strategic Information | $13,047,776 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $10,053,314 |
PDTX: Treatment: Pediatric Treatment | $6,400,362 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $5,631,928 |
HTXD: Treatment: ARV Drugs | $5,490,000 |
PDCS: Care: Pediatric Care and Support | $5,136,292 |
HVTB: Care: TB/HIV | $5,006,225 |
HLAB: Laboratory Infrastructure | $4,837,290 |
HMBL: Biomedical Prevention: Blood Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
John Snow, Inc:
$280,757,923
View countries